Archive
Back to homepageSuper Fierce launches Australia’s first unbiased super fund comparison index that covers 99.8% of the market; reveals Australia’s top 15 funds
Only 15 out of 359 Australian funds outperformed the last 20 years of booms and crashes: the “Fierce Performers” This outperformance amounts to ~$411k more for the average Australian by their retirement The largest outperformance occurred in the ‘Sustainable’ investment
Read MoreHotels Across North and Southeast Asia Choose Geberit Concealed Cisterns to Provide Travelers with the Best Amenities
SINGAPORE, July 13, 2022 /PRNewswire/ – Geberit, the market leader in sanitary products, is helping hotels across the region provide the best amenities for guests with easy-to-install products. Geberit concealed cistern installed behind the wall, with Geberit actuator plate and Geberit
Read MoreHilton ushers in Mid-Autumn with a nationwide Lunar Reunion campaign
KUALA LUMPUR, Malaysia , July 13, 2022 /PRNewswire/ — Hilton Malaysia welcomes the mid-autumn festival with its national mooncake series, Lunar Reunion, featuring an indulgent array of traditional baked varieties of classic and modern flavours. A celebration of craftsmanship and a
Read MoreAmaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31
HSINCHU, July 13, 2022 /PRNewswire/ — Amaran Biotechnology Inc., a subsidiary of Taiwan’s OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first in Taiwan, has been completed. The new facility minimizes
Read MoreGenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies
SEOUL, South Korea, July 12, 2022 /PRNewswire/ — On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor (CAR)-T cell therapy platform targeting solid cancer, announced that
Read More
